Nice to see that across a number of various data p
Post# of 72440
(Total Views: 457)
Posted On: 06/29/2019 1:25:15 PM
Nice to see that across a number of various data points NR is continuing to sink deeper and deeper into the pit they have dug for themselves.
Bottom line appears to be the value of the deal Leo is able to bring to the table; whether OM or IBD not that important IMO as long as it shows he is getting good value for stockholders and BP is showing they value the drugs and indications as highly as does IPIX.
A large IBD deal could really send NR into a tailspin IMO if IPIX receives the upfront monies many of us are expecting, and to a lesser extent, so could a number of different PRs such as finalizing P3 for OM, Euro advancement, pill development for either IBD or Kevetrin (I think more is going on behind the curtain regarding the pill developments than we have been made aware), or other topics that we are not aware (such as possibly more indications that B could address but as of yet have made known, thus raising the platform value of B tremendously and possibly the sale of B or more likely the licensing of the entire platform with one major BP with individual indication payments to be established as they arise) of yet but which could show thinking outside the box Leo has shown in areas that have taken us by surprise in the past. I think NR fears the unknown in Leo's plans and just what he is currently working on or finalizing as much as the expected announcements.
I thought May and June were going to be big months but everything still on the launch pad. July looking very promising but time will tell.
NR - keep digging as IPIX is willing to bury you when the time is right
Bottom line appears to be the value of the deal Leo is able to bring to the table; whether OM or IBD not that important IMO as long as it shows he is getting good value for stockholders and BP is showing they value the drugs and indications as highly as does IPIX.
A large IBD deal could really send NR into a tailspin IMO if IPIX receives the upfront monies many of us are expecting, and to a lesser extent, so could a number of different PRs such as finalizing P3 for OM, Euro advancement, pill development for either IBD or Kevetrin (I think more is going on behind the curtain regarding the pill developments than we have been made aware), or other topics that we are not aware (such as possibly more indications that B could address but as of yet have made known, thus raising the platform value of B tremendously and possibly the sale of B or more likely the licensing of the entire platform with one major BP with individual indication payments to be established as they arise) of yet but which could show thinking outside the box Leo has shown in areas that have taken us by surprise in the past. I think NR fears the unknown in Leo's plans and just what he is currently working on or finalizing as much as the expected announcements.
I thought May and June were going to be big months but everything still on the launch pad. July looking very promising but time will tell.
NR - keep digging as IPIX is willing to bury you when the time is right
(10)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼